Overview

Biologic Correlative Taxotere/AC

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
We are asking you to take part in a research study of biomarkers (characteristics or traits of the genes inside cancer cells). We want to learn if these biomarkers could help us learn how well your breast cancer may respond (improve) to chemotherapy (drugs to treat cancer).
Phase:
Phase 2
Details
Lead Sponsor:
Baylor Breast Care Center
Collaborator:
Baylor College of Medicine
Treatments:
Cyclophosphamide
Docetaxel
Doxorubicin
Liposomal doxorubicin